Report Urges Biopharma to Undergo Radical Changes as Genomics Evolve | GenomeWeb

NEW YORK, Nov. 26 - Biopharmaceutical companies must undergo "radical changes" in order to keep pace with the opportunities introduced by genomics, and companies in the genomics sector should expect an era of consolidation, a recent analysis from a management consulting firm has shown.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.